This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Analysts' Actions: RIMM AIG AOL JCP FRX

Oasis Petroleum (OAS) upgraded at Wells Fargo to outperform from market perform, Wells Fargo said. $40 to $45 valuation range. Strong operational momentum.

Principal Financial (PFG) downgraded at UBS to sell from neutral, UBS said. $27 price target. Accumulation business to remain under pressure.

Philip Morris (PM) upgraded at Goldman from neutral to buy, Goldman Sachs said. $103 price target. Company was also placed on the Conviction Buy list. Company offers growth and yield at an attractive valuation.

Pepco (POM) downgraded at Credit Suisse from outperform to neutral, Credit Suisse said. $20.50 price target. Company is facing multiple growth headwinds.

Perrigo (PRGO) downgraded at Goldman from neutral to sell, Goldman Sachs said. $110 price target. Growth could slow in the next few quarters.

Research in Motion (RIMM) downgraded at BMO to underperform, BMO Capital said. $9 price target. New BB10 phones will likely not stem market share losses.

JM Smucker (SJM) downgraded at Goldman from buy to neutral, Goldman Sachs said. Valuation call, based on a $93 price target.

SodaStream International (SODA) rated new buy at Citigroup. $60 price target. Skeptics abound but momentum is hard to dispute.

Standard Pacific (SPF) downgraded at JP Morgan from neutral to underweight, JP Morgan said. Valuation call, as the stock trades at a 35% premium to its peers.

Molson Coors (TAP) rated new buy at Nomura. $54 price target. Investor sentiment is too low and the company can continue to cut costs.

Tenet Healthcare (THC) upgraded at BofA/Merrill from neutral to buy, Bank of America/Merrill Lynch said. $44 price target. Company is improving margins and leveraging its balance sheet.

Targa Resources (TRGP) downgraded at BofA to neutral from buy, Bank of America Merrill Lynch said. $60 price target. Valuation call.

Watson Pharmaceuticals (WPI) downgraded at Goldman from buy to neutral, Goldman Sachs said. $96 price target. Valuation call, as the stock gained 43% in 2012.

Watsco (WSO) downgraded at JP Morgan to underweight, JP Morgan said. Valuation call, based on a $72 price target.

2 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,083.26 +52.12 0.31%
S&P 500 1,988.14 +4.01 0.20%
NASDAQ 4,516.5530 -2.3490 -0.05%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs